百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02315 百奥赛图-B

交易中 04-29 14:40:55

50.550

-1.150

-2.22%

最高52.500	最低50.100	成交量113.15万
今开51.900	昨收51.700	日振幅4.64%
总市值225.96亿	流通市值56.11亿	总股本4.47亿
成交额5,800万	换手率1.02%	流通股本1.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":50.55,"timestamp":1777444848877,"preClose":51.7,"halted":0,"volume":1131500,"delay":0,"changeRate":-0.022243713733075543,"floatShares":111000000,"shares":447000000,"eps":0.43,"marketStatus":"交易中","change":-1.15,"latestTime":"04-29 14:40:55","open":51.9,"high":52.5,"low":50.1,"amount":58004500,"amplitude":0.046422,"askPrice":50.8,"askSize":5000,"bidPrice":50.55,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":0.736,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777450200000},"marketStatusCode":2,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":51.7,"openAndCloseTimeList":[[1777426200000,1777435200000],[1777438800000,1777449600000]],"volumeRatio":0.772253,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"百奥赛图","latestPrice":94.51,"timestamp":1777444854000,"preClose":96.2,"halted":0,"volume":2362300,"delay":0,"premium":"-53.34"}},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"1110427861","title":"异动解读 | 百奥赛图-B盘中大涨9.18%，一季度纯利增近9倍及拟投建研发基地","url":"https://stock-news.laohu8.com/highlight/detail?id=1110427861","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110427861?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:59","pubTimestamp":1777341555,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315)今日盘中大涨9.18%，引起了市场的广泛关注。消息面上，公司发布2026年第一季度财报，显示营业收入为4.33亿元，同比增长73.68%；归母净利润达到1.04亿元，同比大幅增长885.41%。业绩增长主要得益于药理药效服务需求的增加。此外，公司公告拟通过全资子公司投资约人民币16亿元，建设百奥赛图模式动物与抗体药物研发基地项目，包括动物中心及实验设施等，这进一步增强了市场对公司未来发展的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630264347","title":"百奥赛图-B盘中涨超9% 第一季度纯利大增近9倍至1.04亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630264347","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630264347?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:59","pubTimestamp":1777341540,"startTime":"0","endTime":"0","summary":"　　百奥赛图-B盘中涨超9%，截至发稿，涨幅收窄，微涨1.61%，现报59.80港元，成交额7496.06万港元。　　百奥赛图发布2026年一季报，公司一季度实现营业收入4.33亿元，同比增长73.68%；归母净利润1.04亿元，同比增长885.41%。　　值得注意的是，百奥赛图发布公告称，公司拟通过全资子公司百奥赛图江苏基因生物技术有限公司投资建设百奥赛图模式动物与抗体药物研发基地项目，投资金额约人民币16亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-04-28/doc-inhvzfsh8590424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02315","BK1161","688796","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126798964","title":"百奥赛图-B第一财季营收4.33亿元，经调整净利润0.91亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126798964","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126798964?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:37","pubTimestamp":1777279042,"startTime":"0","endTime":"0","summary":"本季度信息\n根据公告，百奥赛图-B在截至2026年3月31日的第一财季实现营业收入4.33亿元，同比增长73.68%。经调整净利润（扣除非经常性损益后归属于上市公司股东的净利润）录得0.91亿元，较上年同期由亏转盈。经营活动产生的现金流量净额为1.45亿元，同比大增325.80%。本期研发投入约1.18亿元，占营业收入比重27.18%，较上年同期减少12.10个百分点。\n业务分项\n公司营业收入增长主要来自药理药效服务与模式动物领域的收入大幅增加。公告显示，收入提升和费用管理推动了公司整体经营效率的提升，同时研发投入依旧保持稳健增长。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"百奥赛图-B第一财季营收4.33亿元，经调整净利润0.91亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630366544","title":"百奥赛图-B(02315)发布第一季度业绩，归母净利润1.04亿元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2630366544","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630366544?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:35","pubTimestamp":1777278929,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百奥赛图-B(02315)发布截至2026年3月31日止三个月的第一季度业绩，该集团取得营业收入4.33亿元，同比增加73.68%;归属于上市公司股东的净利润1.04亿元，去年同期则亏损1324.58万元;基本每股收益0.23元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434381.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688796","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629505895","title":"港股异动 | 百奥赛图-B(02315)早盘涨超4% 25年利润端爆发式增长 BD授权打开长期成长弹性","url":"https://stock-news.laohu8.com/highlight/detail?id=2629505895","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629505895?lang=zh_cn&edition=full","pubTime":"2026-04-24 10:27","pubTimestamp":1776997653,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B早盘涨超4%，截至发稿，涨4.1%，报59.6港元，成交额2645.96万港元。消息面上，消息面上，百奥赛图发布2025年度业绩，公司实现营业收入13.79亿元，同比增长40.63%，归母净利润1.73亿元，同比增长416.37%，扣非净利润1.16亿元，同比增长405.39%。继2024年首次扭亏后，公司2025年利润端呈现爆发式增长。未来海外高毛利业务有望持续扩张以及后续高频BD合作有望陆续兑现，有望持续为公司注入强劲的长期业绩动能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688796","BK4585","BK0216","BK4588","02315","BK1161","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127644992","title":"百奥赛图-B2025年收入大幅攀升并回A上市，多元化抗体平台推动盈利翻倍增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1127644992","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127644992?lang=zh_cn&edition=full","pubTime":"2026-04-21 16:42","pubTimestamp":1776760977,"startTime":"0","endTime":"0","summary":"百奥赛图-B于2025年在经营规模和财务表现方面实现显著提升，并成功完成A股发行，形成H股与A股双重上市架构。公司报告期内营业收入达13.79亿元人民币，同比增长约40.6%，净利润达到1.73亿元人民币，较上一年度增长416.4%，盈利能力逐步进入规模化发展阶段。随着2025年底顺利实现扭亏与A股上市，公司进一步巩固了在人源化鼠模型及抗体研发赛道的行业地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百奥赛图-B2025年收入大幅攀升并回A上市，多元化抗体平台推动盈利翻倍增长","news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627245420","title":"港股概念追踪 | 创新药板块迎政策东风 国办发文健全药品价格形成机制（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2627245420","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627245420?lang=zh_cn&edition=full","pubTime":"2026-04-15 07:16","pubTimestamp":1776208598,"startTime":"0","endTime":"0","summary":"意见从4个方面提出14条举措，包括完善重点环节药品价格政策、推动相关主体发挥药品价格发现作用、引导关键领域药品价格保持合理水平、加强药品价格治理。具体举措包括优化创新药等新上市药品首发价格机制、发挥医保支付标准对药品价格形成的引导作用、健全药品集中带量采购价格形成机制、完善药品挂网价格管理。《意见》发布后，市场普遍认为新政将为医药产业特别是创新药带来发展新契机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0359202008.SGD","LU0819121731.USD","BK4585","BK1141","BK1610","LU0326950275.SGD","BK1583","LU0320764599.SGD","LU0588546209.SGD","LU0516422440.USD","SG9999002463.SGD","VXUS","02315","06127","LU0052750758.USD","LU0043850808.USD","159992","LU0823426308.USD","BK1589","LU0181495838.USD","LU0359201612.USD","LU0516422952.EUR","LU0856984785.SGD","BK1574","BK1161","LU1242518857.USD","LU0348735423.USD","LU0307460666.USD","02269","LU2039709279.SGD","IE00B0JY6N72.USD","LU0572944931.SGD","LU2045819591.USD","LU0051755006.USD","LU2242644610.SGD","LU0417516902.SGD","LU0140636845.USD","LU0979878070.USD","LU1242518931.SGD","LU0327786744.USD","LU0516422366.SGD","LU0516423091.SGD","LU0039217434.USD","LU0708995583.HKD","02359","LU0456827905.SGD","LU0348825331.USD","06978","03347","LU1046422090.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627418617","title":"港股异动 | 百奥赛图-B(02315)尾盘涨超7% AI自动化体系有望加速“千鼠万抗”潜力释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2627418617","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627418617?lang=zh_cn&edition=full","pubTime":"2026-04-14 15:14","pubTimestamp":1776150897,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B尾盘涨超7%，截至发稿，涨7.06%，报61港元，成交额1.14亿港元。消息面上，4月9日，四环医药与百奥赛图正式签署战略合作协定。双方将依托百奥赛图领先的全人抗体开发平台，结合四环医药在药物开发、生产和商业化方面的深厚经验，围绕减重等多个疾病领域的创新药物研发开展合作与交流。AI自动化体系有望加速“千鼠万抗”潜力释放，打造高效率、规模化的研发生产体系。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428213.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","AGIX","VXUS","BK0216","BK1161","688796","CHAT","ARTY","02315","BK4588","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131915378","title":"百奥赛图-B3月无新增发行，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1131915378","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131915378?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:56","pubTimestamp":1775724990,"startTime":"0","endTime":"0","summary":"百奥赛图(北京)医药科技股份有限公司于2026年4月9日发布2026年3月股份变动月报表，报告期为2026年3月。公告显示，公司在本月未发生任何新增股份发行、回购或注销事项，整体股本维持不变。百奥赛图(北京)医药科技股份有限公司的注册股本合计为446,898,420股。公告同时确认公司已符合香港联交所相关公众持股量要求。公告称，截至3月末，公司整体股份数无变化，股本结构保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624868522","title":"港股百奥赛图-B涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624868522","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624868522?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:43","pubTimestamp":1775101431,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月2日，百奥赛图-B(02315.HK)涨超6%，截至发稿涨6.3%，报63.3港元，成交额5601.17万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604023693164980.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604023693164980.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK4585","VXUS","688796","02315","BK4588","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624052499","title":"百奥赛图-B午前涨超5% 与百奥赛图正式签署战略合作协定","url":"https://stock-news.laohu8.com/highlight/detail?id=2624052499","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624052499?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:39","pubTimestamp":1775101140,"startTime":"0","endTime":"0","summary":"　　百奥赛图-B盘中涨超6%，截至发稿，股价上涨5.29%，现报62.70港元，成交额5695.47万港元。　　四环医药与百奥赛图正式签署战略合作协定。双方将依托百奥赛图领先的全人抗体开发平台，结合四环医药在药物开发、生产和商业化方面的深厚经验，围绕减重等多个疾病领域的创新药物研发开展合作与交流，推动优势互补与资源协同，建立长期、稳定的合作关系。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-04-02/doc-inhtaqzu2025048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688796","02315","BK1161","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110004282","title":"异动解读 | 百奥赛图-B与四环医药达成战略合作，盘中大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110004282","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110004282?lang=zh_cn&edition=full","pubTime":"2026-04-02 10:51","pubTimestamp":1775098276,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315)今日盘中大涨5.12%，引发了市场的广泛关注。消息面上，百奥赛图-B与四环医药(00460)正式签署战略合作协议。根据协议，双方将基于优势互补与专业协同的原则，结合四环医药在药物开发、规模化生产及商业化方面的全产业链经验，以及百奥赛图业内领先的AI驱动全人抗体开发平台核心技术，在减重等多个高潜力疾病领域开展创新药物的联合研发工作。此次合作旨在建立长期稳定、互利共赢的关系，共同推动全球前沿创新药的研发落地与商业化布局。市场分析认为，这一战略合作增强了市场对百奥赛图-B未来在创新药研发领域增长潜力的信心，是推动其股价上涨的直接原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624251435","title":"港股公告掘金 | 百奥赛图-B与四环医药(00460)达成战略合作 加速减重等多领域创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2624251435","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624251435?lang=zh_cn&edition=full","pubTime":"2026-04-02 08:59","pubTimestamp":1775091553,"startTime":"0","endTime":"0","summary":"重大事项：百奥赛图-B(02315)与四环医药(00460)达成战略合作 加速减重等多领域创新药研发远东发展(00035)拟出售墨尔本丽思卡尔顿酒店49.9%权益大唐环境(01272)拟斥资约2457.41万元收购报废风电设备荣昌生物(09995)：国家药监局批准双特异性抗体药物偶联物(双抗ADC)注射用RC288开展临床试验易生活控股(00223)：与雅澳供应链启动AI数字供应链战略合作经营业绩","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LU0254981946.USD","LU0531971595.HKD","LU1251922891.USD","LU0417516902.SGD","SG9999001226.SGD","LU0293314216.USD","BK1589","LU1242518931.SGD","BK1509","LU2294711713.HKD","BK1539","LU2097828805.USD","EVS.SI","LU0314109678.HKD","SG9999015986.USD","BK1161","LU0594300179.USD","BK1521","LU0823414551.USD","LU0588545904.SGD","LU0043850808.USD","LU2476274720.SGD","IE00BZ08YS42.EUR","81211","BK1191","LU1188198961.HKD","LU1808992512.USD","LU2399975544.HKD","LU0979878070.USD","LU2097828714.EUR","LU0143863198.USD","002594","LU0516423174.USD","LU2039709279.SGD","LU0634319403.HKD","LU0052750758.USD","LU1961090484.USD","BK0216","LU2357125470.USD","SG9999014674.SGD","LU0823426308.USD","GELYY","LU0039217434.USD","LU1868838027.USD","80175","LU0823426480.USD","SG9999015945.SGD","LU1282651048.USD","BK1540","BK1582","LU0164865239.USD","LU0823039010.USD","SG9999002828.SGD","LU0449509016.USD","LU0326950275.SGD","LU0315178854.USD","BK1600","LU1770034418.SGD","BK1594","LU0359201612.USD","SG9999006514.SGD","LU1023057109.AUD","IE00BZ08YT58.USD","LU0516422952.EUR","LU0531970944.HKD","BK1515","LU0211977185.USD","LU0463099449.HKD","LU0516422366.SGD","LU0561508036.HKD","LU0417516738.SGD","SG9999015952.SGD","LU2449936058.SGD","LU0289739343.SGD","LU0165289439.USD","LU1813983027.USD","LU0516422440.USD","LU0449515922.USD","BYDDY","LU0543330566.HKD","LU0593848301.USD","LU0244354667.USD","LU2249611893.SGD","LU1720050803.USD","SG9999006597.SGD","LU0540923850.HKD","LU1861219969.SGD","02315","LU1719994722.HKD","BK1574","LU0828238088.HKD","LU0516423091.SGD","SG9999015978.USD","LU0348735423.USD","LU1868837722.USD","LU0588545730.USD","LU1868837565.USD","LU0823414478.USD","LU0469268626.HKD","BK1593","LU0289961442.SGD","LU0214875030.USD","LU0588545490.SGD","LU0594300419.USD","LU0505663152.USD","LU2360107325.USD","LU0823038988.USD","LU2153592121.USD","688796","LU0348827113.USD","LU1224444064.USD","LU0509642566.USD","LU0865486749.SGD","LU1328277881.USD","LU0259732245.USD","LU0650527681.SGD","LU0315179316.USD","LU0348825331.USD","BK1610","BK4588","LU0572944931.SGD","LU1794554557.SGD","IE00BD6J9T35.USD","LU1880383440.USD","SG9999002463.SGD","LU0348805143.USD","LU0708995583.HKD","LU0164872284.USD","LU0819123356.HKD","LU1242518857.USD","LU1282651121.HKD","LU0359201885.HKD","LU0588546209.SGD","LU2506951792.HKD","LU0289960550.SGD","LU0871576103.HKD","LU0511384066.AUD","LU2097828474.EUR","LU2097828631.EUR","00460","LU1303224171.USD","LU0143863784.USD","LU0819121731.USD","HYDD.SI","LU0269904917.USD","LU0359202008.SGD","LU2097828557.USD","LU1861214812.USD","LU0229945570.USD","LU0856984785.SGD","LU2778985437.USD","LU0054450605.USD","IE00B0JY6N72.USD","BK1119","BK1124","BK1522","LU0320764599.SGD","LU2476274308.USD","LU0605514214.HKD","LU1880383366.USD","IE00BZ08YR35.GBP","LU0175139822.USD","LU0084288322.USD","LU0327786744.USD","LU2348774022.SGD","BK1240","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624540176","title":"智通港股早知道 | 美国执行载人绕月任务火箭发射升空 国际能源署署长：4月石油供应缺口将达到3月的两倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2624540176","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624540176?lang=zh_cn&edition=full","pubTime":"2026-04-02 07:33","pubTimestamp":1775086385,"startTime":"0","endTime":"0","summary":"美国执行载人绕月任务火箭发射升空当地时间4月1日傍晚，美国航空航天局新一代登月火箭“太空发射系统”从佛罗里达州肯尼迪航天中心发射升空，执行“阿耳忒弥斯2号”载人绕月任务。这是美国自1972年以来首次载人飞向月球。据知情人士透露，这家卫星制造与火箭发射公司已以保密方式递交上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0067412154.USD","LU1993786604.SGD","LU1807302812.USD","LU1152091168.USD","BK1161","300759","XLE","02315","BK1116","BK4585","BK1600","BK1141","LU1152091754.HKD","03750","LU1008478684.HKD","LU0880133367.SGD","01857","03759","300750","BK1576","02256","06681","00460","BK1515","BK1610","688796","BK1194","BK4588","BK1191","BK4570","LU1960683339.HKD","BK1593","XOP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624960675","title":"四环医药(00460)与百奥赛图(02315)达成战略合作 通过AI驱动的全人抗体研发平台加速减重等多领域创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2624960675","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624960675?lang=zh_cn&edition=full","pubTime":"2026-04-01 17:06","pubTimestamp":1775034361,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环医药 发布公告，集团与百奥赛图(北京)医药科技股份有限公司正式签署战略合作协定。双方将立足优势互补与专业协同的合作原则，凭借集团在药物开发、规模化生产及商业化环节的全产业链成熟经验，结合百奥赛图业内领先的AI驱动全人抗体开发平台核心技术，在减重等多个高潜力疾病领域开展创新药物联合研发工作，建立长期稳定、互利共赢的合作关系，共同推动全球前沿创新药的研发落地与商业化布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688796","BK1574","159992","BK1515","AGIX","BK1191","00460","06978","BK1593","CHAT","BK0216","BK1600","BK1161","02315","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623612963","title":"净利跑出416%增速，百奥赛图-B(02315)迎来商业化兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2623612963","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623612963?lang=zh_cn&edition=full","pubTime":"2026-03-30 09:06","pubTimestamp":1774832793,"startTime":"0","endTime":"0","summary":"2026年，创新药板块迎来多重利好共振，行业回暖态势明确。2025年，公司模式动物业务收入6.22亿元，同比增长近60%，毛利率超80%，持续贡献稳定现金流。2025年，百奥赛图抗体开发业务实现收入3.32亿元，毛利率达86%;累计签署超350项合作协议，其中2025年就新增150余项。短期业绩利好催化股价上行，叠加长期价值逐步显现，百奥赛图凭借其创新技术、稀缺的商业模式与全球新药研发体系中的有利卡位，有望率先受益于行业景气度回升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","BK1161","02315","688796"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622045816","title":"港股异动 | 百奥赛图-B(02315)涨超12% 全年纯利同比增超4倍 海外业务实现快速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2622045816","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622045816?lang=zh_cn&edition=full","pubTime":"2026-03-27 10:39","pubTimestamp":1774579145,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B涨超12%，截至发稿，涨11.99%，报60.25港元，成交额7808.72万港元。消息面上，百奥赛图发布2025年度业绩，公司实现营业收入13.79亿元，同比增长40.63%，归母净利润1.73亿元，同比增长416.37%，扣非净利润1.16亿元，同比增长405.39%。值得关注的是，百奥赛图全球化布局成果卓越，2025年海外收入占比近70%，服务网络覆盖美国，欧洲和亚太市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","688796","BK0216","VXUS","BK1161","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622986952","title":"百奥赛图-B(02315)合作伙伴NEOK Bio双抗ADC NEOK002获FDA IND许可，合作迈入关键里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=2622986952","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622986952?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:35","pubTimestamp":1774535741,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百奥赛图-B 发布公告，本公司合作伙伴NEOK Bio, Inc.近日获得美国食品药品监督管理局对其在研新药NEOK002的新药临床试验申请批准。NEOK Bio计划于2026年第二季度启动I期临床试验，并预计于2027年公布初步临床数据。此次IND获批标志着NEOK002项目取得重要里程碑进展。NEOK002基于百奥赛图自主开发并于2024年对外授权的双特异性抗体构建，由NEOK Bio进一步推进 ADC药物开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","BK1161","BK4588","02315","688796","BK0216","BK4080","ADC","IND","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621051654","title":"港股百奥赛图-B涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621051654","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621051654?lang=zh_cn&edition=full","pubTime":"2026-03-24 15:14","pubTimestamp":1774336484,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月24日，百奥赛图-B(02315.HK)涨超12%，截至发稿，涨12.14%，报54.5港元，成交额1.6亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603243682503514.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603243682503514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VXUS","BK4585","BK1161","BK0216","BK4588","688796","02315"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621105609","title":"港股异动 | 百奥赛图-B(02315)涨超12% 与Moonlight Bio达成战略合作 去年纯利同比预增超四倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2621105609","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621105609?lang=zh_cn&edition=full","pubTime":"2026-03-24 14:58","pubTimestamp":1774335519,"startTime":"0","endTime":"0","summary":"消息面上，3月23日，百奥赛图宣布与总部位于西雅图、深耕前沿细胞疗法的生物技术公司Moonlight Bio, Inc.达成战略合作协议。根据协议条款，百奥赛图将提供针对治疗靶点的全人抗体分子，Moonlight Bio将负责相关细胞疗法的临床前开发工作。此外，百奥赛图此前发布2025年度业绩快报，预计2025年营业收入约为13.79亿元，同比增长40.63%；实现归属于公司所有者的净利润人民币1.73亿元，同比增长416.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK4585","VXUS","688796","02315","BK4588","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":-0.0946},{"period":"1month","weight":-0.1155},{"period":"3month","weight":0.1},{"period":"6month","weight":0.9977},{"period":"1year","weight":3.2657},{"period":"ytd","weight":0.4646}],"compareEarnings":[{"period":"1week","weight":-0.0305},{"period":"1month","weight":0.0292},{"period":"3month","weight":-0.0772},{"period":"6month","weight":-0.0229},{"period":"1year","weight":0.1688},{"period":"ytd","weight":0.0019}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百奥赛图（北京）医药科技股份有限公司是一家主要基于自主开发的基因编辑技术提供各类创新模式动物以及临床前阶段的医药研发服务的中国公司。该公司利用其自主开发的“RenMice”全人源抗体和T细胞受体（TCR）小鼠平台针对人体内潜在药物靶点进行规模化药物发现与开发。该公司主要业务包括创新模式动物销售、临床前药理药效评价服务及抗体开发。该公司还提供基因编辑服务。该公司在中国国内市场及海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.018702},{"month":2,"riseRate":0.75,"avgChangeRate":0.087225},{"month":3,"riseRate":0.5,"avgChangeRate":0.15364},{"month":4,"riseRate":0.25,"avgChangeRate":-0.066425},{"month":5,"riseRate":0.666667,"avgChangeRate":0.14952},{"month":6,"riseRate":0.333333,"avgChangeRate":0.011218},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.033427},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.055975},{"month":9,"riseRate":0.666667,"avgChangeRate":0.092895},{"month":10,"riseRate":0.25,"avgChangeRate":-0.096483},{"month":11,"riseRate":0.5,"avgChangeRate":0.009059},{"month":12,"riseRate":0.5,"avgChangeRate":0.137663}],"exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}